相关实验视频

Updated: Jan 10, 2026

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Published on: May 23, 2025

新兴的创新治疗方法用于乳腺瘤转移性瘤

Nobuhiko Kanaya¹, Khalid Shah²

¹Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Trends in molecular medicine

|November 19, 2025

概括

乳腺瘤转移 (LM) 治疗正在通过向疗法,免疫疗法和先进的药物输送得到改善. 这些创新为患有这种晚期癌症并发症的患者提供了新的希望.

科学领域:

在瘤学瘤学.
神经学神经学
癌症研究癌症研究

背景情况:

瘦骨内转移 (LM) 是晚期固体瘤的严重并发症.
目前用于LM的治疗方法的疗效有限,毒性显著.
药物透到中枢神经系统的不足,阻碍了传统治疗.

研究的目的:

审查最近在莱普托门转移病的管理方面取得的进展.
突出新的治疗策略及其临床影响.
讨论LM治疗的不断变化的格局.

主要方法:

对LM疗法的临床前和临床研究的审查.
分析针对性治疗,免疫疗法和药物输送方面的进展.
检查新药和治疗方式.

主要成果:

穿透大脑的药物在LM中表现出改善的结果.
抗体和免疫检查点抑制剂 (ICI) 的内注射扩大了治疗选择.
像CAR-T细胞和干细胞疗法这样的免疫疗法在对抗LM的微环境方面表现有前途.

结论:

最近的创新正在改变LM管理.
新的治疗方法为LM患者提供了新的潜力.
该审查强调了治疗勒普托门瘤转移的范式转变.

关键词:

用CAR T细胞疗法进行治疗.免疫疗法免疫疗法内疗法是一种内疗法.莱普托门内尔转移 (leptomeningeal metastasis) 是一种转移.有针对性的治疗.

更多相关视频

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...